Cutler Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-58
| Closed | -$1K | – | 1805 |
|
|
2022
Q4 | $1K | Sell |
58
-67
| -54% | -$1.16K | ﹤0.01% | 1632 |
|
|
2022
Q3 | $2K | Buy |
125
+75
| +150% | +$1.2K | ﹤0.01% | 1729 |
|
|
2022
Q2 | $1K | Buy |
50
+17
| +52% | +$340 | ﹤0.01% | 1790 |
|
|
2022
Q1 | $1K | Sell |
33
-3,137
| -99% | -$95.1K | ﹤0.01% | 1879 |
|
|
2021
Q4 | $189K | Buy |
3,170
+2,970
| +1,485% | +$177K | 0.01% | 716 |
|
|
2021
Q3 | $17K | Sell |
200
-42
| -17% | -$3.57K | ﹤0.01% | 1576 |
|
|
2021
Q2 | $26K | Hold |
242
| – | – | ﹤0.01% | 1457 |
|
|
2021
Q1 | $26K | Sell |
242
-44
| -15% | -$4.73K | ﹤0.01% | 1382 |
|
|
2020
Q4 | $30K | Buy |
286
+178
| +165% | +$18.7K | ﹤0.01% | 1150 |
|
|
2020
Q3 | $15K | Sell |
108
-117
| -52% | -$16.3K | ﹤0.01% | 1223 |
|
|
2020
Q2 | $72K | Buy |
225
+14
| +7% | +$4.48K | ﹤0.01% | 736 |
|
|
2020
Q1 | $18K | Buy |
+211
| New | +$18K | ﹤0.01% | 1013 |
|
|
2018
Q2 | – | Sell |
-25
| Closed | -$1K | – | 1944 |
|
|
2018
Q1 | $1K | Sell |
25
-8
| -24% | -$320 | ﹤0.01% | 1702 |
|
|
2017
Q4 | $1K | Sell |
33
-355
| -91% | -$10.8K | ﹤0.01% | 1986 |
|
|
2017
Q3 | $29K | Sell |
388
-130
| -25% | -$9.72K | ﹤0.01% | 1501 |
|
|
2017
Q2 | $48K | Buy |
+518
| New | +$48K | ﹤0.01% | 1493 |
|
|
2017
Q1 | – | Sell |
-300
| Closed | -$24K | – | 3071 |
|
|
2016
Q4 | $24K | Buy |
300
+25
| +9% | +$2K | ﹤0.01% | 1832 |
|
|
2016
Q3 | $30K | Sell |
275
-50
| -15% | -$5.46K | ﹤0.01% | 1669 |
|
|
2016
Q2 | $35K | Sell |
325
-273
| -46% | -$29.4K | ﹤0.01% | 1537 |
|
|
2016
Q1 | $62K | Sell |
598
-798
| -57% | -$82.7K | ﹤0.01% | 1188 |
|
|
2015
Q4 | $112K | Buy |
+1,396
| New | +$112K | 0.01% | 978 |
|